Cargando…

Evaluation of Lymphovascular Invasion by CD31 Expression in Gastric Adenocarcinoma

BACKGROUND & OBJECTIVE: Lymphovascular tumoral invasion is a typical histopathological feature of gastric carcinomas and supports the recognition of high-risk patients for the recurrence. We aimed to study CD31 expression in diverse subtypes of gastric carcinomas and to show its association with...

Descripción completa

Detalles Bibliográficos
Autores principales: Miratashi Yazdi, Seyed Amir, Nazar, Elham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Society of Pathology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439755/
https://www.ncbi.nlm.nih.gov/pubmed/37600573
http://dx.doi.org/10.30699/ijp.2023.562466.2977
_version_ 1785093020598665216
author Miratashi Yazdi, Seyed Amir
Nazar, Elham
author_facet Miratashi Yazdi, Seyed Amir
Nazar, Elham
author_sort Miratashi Yazdi, Seyed Amir
collection PubMed
description BACKGROUND & OBJECTIVE: Lymphovascular tumoral invasion is a typical histopathological feature of gastric carcinomas and supports the recognition of high-risk patients for the recurrence. We aimed to study CD31 expression in diverse subtypes of gastric carcinomas and to show its association with the histopathologic findings of the carcinoma to assess the prognosis. METHODS: This cross-sectional study was conducted on 40 established patients with gastric adenocarcinoma from radical gastrectomy. The patients were classified according to the pathology assessments. Tumoral tissues were assessed by immunohistochemical staining for CD31 expression. Malignant behavior was estimated by histopathological evaluations. RESULTS: CD31 positivity was described in 23 (57.5%) of all evaluated patients. In assessment of CD31 expression and tumor features presented, no significant association between the CD31 expression and patients’ age, sex, tumor site, size, grade and stage, subtypes of carcinoma, perineural invasion, and also lymphovascular invasion was found. (P>0.05). CONCLUSION: Lymphovascular invasion may make valuable additional evidence and may be useful to detect gastric carcinoma patients at high risk for recurrence, who could be candidates for more supplementary therapies. However, in our study, CD31 expression did not show any association with the aggressive histopathologic features of this tumor.
format Online
Article
Text
id pubmed-10439755
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Iranian Society of Pathology
record_format MEDLINE/PubMed
spelling pubmed-104397552023-08-20 Evaluation of Lymphovascular Invasion by CD31 Expression in Gastric Adenocarcinoma Miratashi Yazdi, Seyed Amir Nazar, Elham Iran J Pathol Original Article BACKGROUND & OBJECTIVE: Lymphovascular tumoral invasion is a typical histopathological feature of gastric carcinomas and supports the recognition of high-risk patients for the recurrence. We aimed to study CD31 expression in diverse subtypes of gastric carcinomas and to show its association with the histopathologic findings of the carcinoma to assess the prognosis. METHODS: This cross-sectional study was conducted on 40 established patients with gastric adenocarcinoma from radical gastrectomy. The patients were classified according to the pathology assessments. Tumoral tissues were assessed by immunohistochemical staining for CD31 expression. Malignant behavior was estimated by histopathological evaluations. RESULTS: CD31 positivity was described in 23 (57.5%) of all evaluated patients. In assessment of CD31 expression and tumor features presented, no significant association between the CD31 expression and patients’ age, sex, tumor site, size, grade and stage, subtypes of carcinoma, perineural invasion, and also lymphovascular invasion was found. (P>0.05). CONCLUSION: Lymphovascular invasion may make valuable additional evidence and may be useful to detect gastric carcinoma patients at high risk for recurrence, who could be candidates for more supplementary therapies. However, in our study, CD31 expression did not show any association with the aggressive histopathologic features of this tumor. Iranian Society of Pathology 2023 2023-06-20 /pmc/articles/PMC10439755/ /pubmed/37600573 http://dx.doi.org/10.30699/ijp.2023.562466.2977 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution- 4.0 International License (https://creativecommons.org/licenses/by/4.0/) which permits Share, copy and redistribution of the material in any medium or format or adapt, remix, transform, and build upon the material for any purpose, even commercially.
spellingShingle Original Article
Miratashi Yazdi, Seyed Amir
Nazar, Elham
Evaluation of Lymphovascular Invasion by CD31 Expression in Gastric Adenocarcinoma
title Evaluation of Lymphovascular Invasion by CD31 Expression in Gastric Adenocarcinoma
title_full Evaluation of Lymphovascular Invasion by CD31 Expression in Gastric Adenocarcinoma
title_fullStr Evaluation of Lymphovascular Invasion by CD31 Expression in Gastric Adenocarcinoma
title_full_unstemmed Evaluation of Lymphovascular Invasion by CD31 Expression in Gastric Adenocarcinoma
title_short Evaluation of Lymphovascular Invasion by CD31 Expression in Gastric Adenocarcinoma
title_sort evaluation of lymphovascular invasion by cd31 expression in gastric adenocarcinoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439755/
https://www.ncbi.nlm.nih.gov/pubmed/37600573
http://dx.doi.org/10.30699/ijp.2023.562466.2977
work_keys_str_mv AT miratashiyazdiseyedamir evaluationoflymphovascularinvasionbycd31expressioningastricadenocarcinoma
AT nazarelham evaluationoflymphovascularinvasionbycd31expressioningastricadenocarcinoma